Diagnostic and Staging Value of Inter-Alpha-Trypsin Inhibitor Heavy Chain Family Member 4, Neutrophil Gelatinase-Associated Lipocalin, and Fibronectin Type III Domain-Containing Protein 5 as Non-Invasive Biomarkers for Endometriosis

Saba muhammed jassim, Banan Natiq Turkey
In: 10.46966/msjar.v7i3 · 2026 · W7217363580
OA: diamond CC0
🔓 Open OA copy View on OpenAlex
⚙ AI-generated summary by qwen3.7-flash, 2026-10-26 ⓘ

Serum ITIH4, NGAL, and FNDC5 levels significantly differ in women with endometriosis compared to healthy controls, demonstrating high diagnostic accuracy and utility for disease staging as non-invasive biomarkers.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Background: Endometriosis remains a diagnostic challenge owing to the reliance on invasive surgical confirmation. The identification of reliable serum biomarkers could facilitate earlier, non-invasive diagnosis and staging. This study aimed to evaluate the diagnostic and staging value of serum inter-alpha-trypsin inhibitor heavy chain family member 4 (ITIH4), neutrophil gelatinase-associated lipocalin (NGAL), and fibronectin type III domain-containing protein 5 (FNDC5) in women with endometriosis. Methods: This case–control study included 100 women: 50 with surgically confirmed endometriosis (27 stage I–II and 23 stage III–IV according to the revised American Society for Reproductive Medicine classification) and 50 age-matched healthy controls. Serum levels of ITIH4, NGAL, and FNDC5 were measured using ELISA. Results: Serum ITIH4 and NGAL levels were significantly elevated in the endometriosis group compared with controls (43.60 ± 11.96 vs. 14.30 ± 2.74 ng/mL; and 135.69 ± 41.89 vs. 41.02 ± 5.82 ng/mL, respectively; both p < 0.001), whilst FNDC5 was significantly reduced (4.17 ± 1.45 vs. 8.44 ± 1.23 ng/mL, p < 0.001). For diagnosis, the AUC values were 0.998 for ITIH4, 0.954 for FNDC5, and 0.984 for CA-125. For staging, FNDC5 achieved an AUC of 0.965, ITIH4 achieved 0.916, and NGAL achieved 0.794. The combined biomarker panel yielded an AUC of 0.995 for staging. Conclusion: Serum ITIH4, NGAL, and FNDC5 demonstrate excellent diagnostic and staging performance for endometriosis and may serve as promising non-invasive biomarkers to complement current diagnostic approaches.

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (24)

Source provenance

openalex
last seen: 2026-11-08T06:02:16.207659+00:00
License: CC0 · commercial use OK